Connecting you to content on EBSCOhost

Works matching IS 0163769X AND DT 2022 AND VI 43 AND IP 2

Results: 8

1

Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma.

Published in:: 2022
Publication type:: Correction Notice

2

Erratum to: Personalized Management of Pheochromocytoma and Paraganglioma.

Published in:: 2022
Publication type:: Correction Notice

3

Optimal Thyroid Hormone Replacement.

Published in:

Endocrine Reviews, 2022, v. 43, n. 2, p. 366, doi. 10.1210/endrev/bnab031

By:

Jonklaas, Jacqueline

Publication type:

Article

4

Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs.

Published in:

Endocrine Reviews, 2022, v. 43, n. 2, p. 329, doi. 10.1210/endrev/bnab030

By:

Rodgers, Buel D;
Ward, Christopher W

Publication type:

Article

5

Secondary Osteoporosis.

Published in:

Endocrine Reviews, 2022, v. 43, n. 2, p. 240, doi. 10.1210/endrev/bnab028

By:

Ebeling, Peter R;
Nguyen, Hanh H;
Aleksova, Jasna;
Vincent, Amanda J;
Wong, Phillip;
Milat, Frances

Publication type:

Article

6

Time-restricted Eating for the Prevention and Management of Metabolic Diseases.

Published in:

Endocrine Reviews, 2022, v. 43, n. 2, p. 405, doi. 10.1210/endrev/bnab027

By:

Manoogian, Emily N C;
Chow, Lisa S;
Taub, Pam R;
Laferrère, Blandine;
Panda, Satchidananda

Publication type:

Article

7

Arcuate Nucleus-Dependent Regulation of Metabolism—Pathways to Obesity and Diabetes Mellitus.

Published in:

Endocrine Reviews, 2022, v. 43, n. 2, p. 314, doi. 10.1210/endrev/bnab025

By:

Jais, Alexander;
Brüning, Jens C

Publication type:

Article

8

Personalized Management of Pheochromocytoma and Paraganglioma.

Published in:

Endocrine Reviews, 2022, v. 43, n. 2, p. 199, doi. 10.1210/endrev/bnab019

By:

Nölting, Svenja;
Bechmann, Nicole;
Taieb, David;
Beuschlein, Felix;
Fassnacht, Martin;
Kroiss, Matthias;
Eisenhofer, Graeme;
Grossman, Ashley;
Pacak, Karel

Publication type:

Article